Bank of New York Mellon’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-30
Closed -$3.99K 4446
2022
Q4
$3.99K Hold
30
﹤0.01% 4453
2022
Q3
$6K Hold
30
﹤0.01% 4529
2022
Q2
$10K Hold
30
﹤0.01% 4548
2022
Q1
$18K Hold
30
﹤0.01% 4624
2021
Q4
$27K Hold
30
﹤0.01% 4567
2021
Q3
$37K Hold
30
﹤0.01% 4472
2021
Q2
$94K Sell
30
-129
-81% -$511K ﹤0.01% 4228
2021
Q1
$979K Buy
159
+6
+4% +$43.5K ﹤0.01% 3341
2020
Q4
$869K Buy
153
+34
+29% +$214K ﹤0.01% 3335
2020
Q3
$710K Buy
119
+20
+20% +$117K ﹤0.01% 3313
2020
Q2
$614K Buy
99
+50
+102% +$339K ﹤0.01% 3372
2020
Q1
$469K Buy
49
+30
+158% +$471K ﹤0.01% 3402
2019
Q4
$320K Hold
19
﹤0.01% 3780
2019
Q3
$309K Buy
19
+5
+36% +$80.7K ﹤0.01% 3772
2019
Q2
$311K Buy
14
+3
+27% +$74.2K ﹤0.01% 3796
2019
Q1
$308K Hold
11
﹤0.01% 3737
2018
Q4
$159K Buy
11
+4
+57% +$89.5K ﹤0.01% 3895
2018
Q3
$252K Buy
7
+1
+17% +$30.9K ﹤0.01% 3873
2018
Q2
$170K Buy
6
+1
+20% +$38.9K ﹤0.01% 3934
2018
Q1
$682K Buy
+5
New +$608K ﹤0.01% 3426

Other funds holding YARW

Bank of New York Mellon's YARW Position: Q1 2023 in Review

Bank of New York Mellon sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2023, closing a stake of 30 shares — an estimated $3.99K sold.

Bank of New York Mellon first reported a position in YARW in Q1 2018 and held it in 20 quarters. The position peaked at $979K in Q1 2021. 21 funds tracked by Wall St. Rank hold YARW as of Q1 2023.

  • Bank of New York Mellon reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Bank of New York Mellon sold 30 Yarrow Bioscience, Inc. Common Stock shares in Q1 2023, an estimated $3.99K.
  • Bank of New York Mellon first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2018 and held it in 20 quarters.
  • Bank of New York Mellon's Yarrow Bioscience, Inc. Common Stock position peaked at $979K in Q1 2021.
  • 21 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2023.

Based on Bank of New York Mellon's 13F filing for Q1 2023, filed 9 May 2023.